Cindy Hsing-Liang Hsu, MD, PhD, MS

Dr. Cindy Hsu is an emergency medicine physician and surgical intensivist who cares for patients in Michigan Medicine’s Adult Emergency Department, Emergency Critical Care Center, and Trauma/Burn Intensive Care Unit. She received her undergraduate degree from the Johns Hopkins University and MD/PhD degree from Boston University with a doctoral degree in pharmacology & experimental therapeutics and biomedical neuroscience. She then completed her emergency medicine residency at the Hospital of the University of Pennsylvania followed by trauma/surgical critical care fellowship at the R Adams Cowley Shock Trauma Center. Most recently, she completed a master’s program in clinical research design and statistical analysis at the University of Michigan. 

Dr. Hsu’s clinical expertise in caring for critically ill and cardiac arrest patients has reinforced her translational research on post-cardiac arrest neuroprotection and prognostication. She has dedicated significant time as an NHLBI K12 Scholar developing large animal cardiac arrest models to study neuroprotective therapies such as high-dose valproic acid, with plan to translate these findings to early-phase clinical trials. Dr. Hsu has expanded the translation of these swine models to study how resuscitative balloon occlusion of the aorta on effects prolonged cardiac arrest outcomes and aerosol generation during cardiopulmonary resuscitation. She has been continuously funded by the NHBLI K12 Career Development Award, NIH Loan Repayment Program, ZOLL Foundation, and most recently, a NINDS R61/33 Innovation Grant to Nurture Initial Translational Efforts that will enable Dr. Hsu to develop a swine model with severe neurologic brain injury to translate novel neurotherapeutics after cardiac arrest.

In addition to her dedications to translational cardiac arrest research, Dr. Hsu has served as the site principal investigator for several multicenter cardiac arrest clinical trials including ICECAP and ACCESS, as well as a lead investigator of a randomized feasibility trial of expedited out-of-hospital cardiac arrest transport called Extracorporeal Cardiopulmonary Resuscitation for Refractory Out-of-Hospital Cardiac Arrest (EROCA). She has also been actively involved in the creation of resuscitation guidelines as a member on the International Liaison Committee on Resuscitation’s Advanced Life Support Task Force and the American Heart Association’s Emergency Cardiovascular Care Science Subcommittee.